Global Taurine and Derivatives Market Growth 2026-2032
The global Taurine and Derivatives market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
United States market for Taurine and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Taurine and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Taurine and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Taurine and Derivatives players cover Yongan Pharmaceutical, Grand Pharma, Jiangyin Huachang, Yuanyang Pharmaceutical, Taisho Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Taurine and Derivatives Industry Forecast” looks at past sales and reviews total world Taurine and Derivatives sales in 2025, providing a comprehensive analysis by region and market sector of projected Taurine and Derivatives sales for 2026 through 2032. With Taurine and Derivatives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Taurine and Derivatives industry.
This Insight Report provides a comprehensive analysis of the global Taurine and Derivatives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Taurine and Derivatives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Taurine and Derivatives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Taurine and Derivatives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Taurine and Derivatives.
This report presents a comprehensive overview, market shares, and growth opportunities of Taurine and Derivatives market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Taurine and Derivatives market?
What factors are driving Taurine and Derivatives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Taurine and Derivatives market opportunities vary by end market size?
How does Taurine and Derivatives break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
United States market for Taurine and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Taurine and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Taurine and Derivatives is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Taurine and Derivatives players cover Yongan Pharmaceutical, Grand Pharma, Jiangyin Huachang, Yuanyang Pharmaceutical, Taisho Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Taurine and Derivatives Industry Forecast” looks at past sales and reviews total world Taurine and Derivatives sales in 2025, providing a comprehensive analysis by region and market sector of projected Taurine and Derivatives sales for 2026 through 2032. With Taurine and Derivatives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Taurine and Derivatives industry.
This Insight Report provides a comprehensive analysis of the global Taurine and Derivatives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Taurine and Derivatives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Taurine and Derivatives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Taurine and Derivatives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Taurine and Derivatives.
This report presents a comprehensive overview, market shares, and growth opportunities of Taurine and Derivatives market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Taurine
- Taurine Derivatives
- Food and Beverages
- Medicine and Health Products
- Feed
- Pet Food
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Yongan Pharmaceutical
- Grand Pharma
- Jiangyin Huachang
- Yuanyang Pharmaceutical
- Taisho Pharmaceutical
- Zhejiang NHU Co., Ltd
- Shengyuan Environmental Protection
What is the 10-year outlook for the global Taurine and Derivatives market?
What factors are driving Taurine and Derivatives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Taurine and Derivatives market opportunities vary by end market size?
How does Taurine and Derivatives break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Taurine and Derivatives Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Taurine and Derivatives by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Taurine and Derivatives by Country/Region, 2021, 2025 & 2032
2.2 Taurine and Derivatives Segment by Type
2.2.1 Taurine
2.2.2 Taurine Derivatives
2.2.3 Taurine and Derivatives Sales by Type
2.2.3.1 Global Taurine and Derivatives Sales Market Share by Type (2021-2026)
2.2.3.2 Global Taurine and Derivatives Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Taurine and Derivatives Sale Price by Type (2021-2026)
2.3 Taurine and Derivatives Segment by Application
2.3.1 Food and Beverages
2.3.2 Medicine and Health Products
2.3.3 Feed
2.3.4 Pet Food
2.3.5 Others
2.3.6 Taurine and Derivatives Sales by Application
2.3.6.1 Global Taurine and Derivatives Sale Market Share by Application (2021-2026)
2.3.6.2 Global Taurine and Derivatives Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Taurine and Derivatives Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Taurine and Derivatives Breakdown Data by Company
3.1.1 Global Taurine and Derivatives Annual Sales by Company (2021-2026)
3.1.2 Global Taurine and Derivatives Sales Market Share by Company (2021-2026)
3.2 Global Taurine and Derivatives Annual Revenue by Company (2021-2026)
3.2.1 Global Taurine and Derivatives Revenue by Company (2021-2026)
3.2.2 Global Taurine and Derivatives Revenue Market Share by Company (2021-2026)
3.3 Global Taurine and Derivatives Sale Price by Company
3.4 Key Manufacturers Taurine and Derivatives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Taurine and Derivatives Product Location Distribution
3.4.2 Players Taurine and Derivatives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TAURINE AND DERIVATIVES BY GEOGRAPHIC REGION
4.1 World Historic Taurine and Derivatives Market Size by Geographic Region (2021-2026)
4.1.1 Global Taurine and Derivatives Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Taurine and Derivatives Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Taurine and Derivatives Market Size by Country/Region (2021-2026)
4.2.1 Global Taurine and Derivatives Annual Sales by Country/Region (2021-2026)
4.2.2 Global Taurine and Derivatives Annual Revenue by Country/Region (2021-2026)
4.3 Americas Taurine and Derivatives Sales Growth
4.4 APAC Taurine and Derivatives Sales Growth
4.5 Europe Taurine and Derivatives Sales Growth
4.6 Middle East & Africa Taurine and Derivatives Sales Growth
5 AMERICAS
5.1 Americas Taurine and Derivatives Sales by Country
5.1.1 Americas Taurine and Derivatives Sales by Country (2021-2026)
5.1.2 Americas Taurine and Derivatives Revenue by Country (2021-2026)
5.2 Americas Taurine and Derivatives Sales by Type (2021-2026)
5.3 Americas Taurine and Derivatives Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Taurine and Derivatives Sales by Region
6.1.1 APAC Taurine and Derivatives Sales by Region (2021-2026)
6.1.2 APAC Taurine and Derivatives Revenue by Region (2021-2026)
6.2 APAC Taurine and Derivatives Sales by Type (2021-2026)
6.3 APAC Taurine and Derivatives Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Taurine and Derivatives by Country
7.1.1 Europe Taurine and Derivatives Sales by Country (2021-2026)
7.1.2 Europe Taurine and Derivatives Revenue by Country (2021-2026)
7.2 Europe Taurine and Derivatives Sales by Type (2021-2026)
7.3 Europe Taurine and Derivatives Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Taurine and Derivatives by Country
8.1.1 Middle East & Africa Taurine and Derivatives Sales by Country (2021-2026)
8.1.2 Middle East & Africa Taurine and Derivatives Revenue by Country (2021-2026)
8.2 Middle East & Africa Taurine and Derivatives Sales by Type (2021-2026)
8.3 Middle East & Africa Taurine and Derivatives Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Taurine and Derivatives
10.3 Manufacturing Process Analysis of Taurine and Derivatives
10.4 Industry Chain Structure of Taurine and Derivatives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Taurine and Derivatives Distributors
11.3 Taurine and Derivatives Customer
12 WORLD FORECAST REVIEW FOR TAURINE AND DERIVATIVES BY GEOGRAPHIC REGION
12.1 Global Taurine and Derivatives Market Size Forecast by Region
12.1.1 Global Taurine and Derivatives Forecast by Region (2027-2032)
12.1.2 Global Taurine and Derivatives Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Taurine and Derivatives Forecast by Type (2027-2032)
12.7 Global Taurine and Derivatives Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Yongan Pharmaceutical
13.1.1 Yongan Pharmaceutical Company Information
13.1.2 Yongan Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
13.1.3 Yongan Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Yongan Pharmaceutical Main Business Overview
13.1.5 Yongan Pharmaceutical Latest Developments
13.2 Grand Pharma
13.2.1 Grand Pharma Company Information
13.2.2 Grand Pharma Taurine and Derivatives Product Portfolios and Specifications
13.2.3 Grand Pharma Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Grand Pharma Main Business Overview
13.2.5 Grand Pharma Latest Developments
13.3 Jiangyin Huachang
13.3.1 Jiangyin Huachang Company Information
13.3.2 Jiangyin Huachang Taurine and Derivatives Product Portfolios and Specifications
13.3.3 Jiangyin Huachang Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jiangyin Huachang Main Business Overview
13.3.5 Jiangyin Huachang Latest Developments
13.4 Yuanyang Pharmaceutical
13.4.1 Yuanyang Pharmaceutical Company Information
13.4.2 Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
13.4.3 Yuanyang Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Yuanyang Pharmaceutical Main Business Overview
13.4.5 Yuanyang Pharmaceutical Latest Developments
13.5 Taisho Pharmaceutical
13.5.1 Taisho Pharmaceutical Company Information
13.5.2 Taisho Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
13.5.3 Taisho Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Taisho Pharmaceutical Main Business Overview
13.5.5 Taisho Pharmaceutical Latest Developments
13.6 Zhejiang NHU Co., Ltd
13.6.1 Zhejiang NHU Co., Ltd Company Information
13.6.2 Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolios and Specifications
13.6.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Zhejiang NHU Co., Ltd Main Business Overview
13.6.5 Zhejiang NHU Co., Ltd Latest Developments
13.7 Shengyuan Environmental Protection
13.7.1 Shengyuan Environmental Protection Company Information
13.7.2 Shengyuan Environmental Protection Taurine and Derivatives Product Portfolios and Specifications
13.7.3 Shengyuan Environmental Protection Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shengyuan Environmental Protection Main Business Overview
13.7.5 Shengyuan Environmental Protection Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Taurine and Derivatives Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Taurine and Derivatives by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Taurine and Derivatives by Country/Region, 2021, 2025 & 2032
2.2 Taurine and Derivatives Segment by Type
2.2.1 Taurine
2.2.2 Taurine Derivatives
2.2.3 Taurine and Derivatives Sales by Type
2.2.3.1 Global Taurine and Derivatives Sales Market Share by Type (2021-2026)
2.2.3.2 Global Taurine and Derivatives Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Taurine and Derivatives Sale Price by Type (2021-2026)
2.3 Taurine and Derivatives Segment by Application
2.3.1 Food and Beverages
2.3.2 Medicine and Health Products
2.3.3 Feed
2.3.4 Pet Food
2.3.5 Others
2.3.6 Taurine and Derivatives Sales by Application
2.3.6.1 Global Taurine and Derivatives Sale Market Share by Application (2021-2026)
2.3.6.2 Global Taurine and Derivatives Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Taurine and Derivatives Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Taurine and Derivatives Breakdown Data by Company
3.1.1 Global Taurine and Derivatives Annual Sales by Company (2021-2026)
3.1.2 Global Taurine and Derivatives Sales Market Share by Company (2021-2026)
3.2 Global Taurine and Derivatives Annual Revenue by Company (2021-2026)
3.2.1 Global Taurine and Derivatives Revenue by Company (2021-2026)
3.2.2 Global Taurine and Derivatives Revenue Market Share by Company (2021-2026)
3.3 Global Taurine and Derivatives Sale Price by Company
3.4 Key Manufacturers Taurine and Derivatives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Taurine and Derivatives Product Location Distribution
3.4.2 Players Taurine and Derivatives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TAURINE AND DERIVATIVES BY GEOGRAPHIC REGION
4.1 World Historic Taurine and Derivatives Market Size by Geographic Region (2021-2026)
4.1.1 Global Taurine and Derivatives Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Taurine and Derivatives Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Taurine and Derivatives Market Size by Country/Region (2021-2026)
4.2.1 Global Taurine and Derivatives Annual Sales by Country/Region (2021-2026)
4.2.2 Global Taurine and Derivatives Annual Revenue by Country/Region (2021-2026)
4.3 Americas Taurine and Derivatives Sales Growth
4.4 APAC Taurine and Derivatives Sales Growth
4.5 Europe Taurine and Derivatives Sales Growth
4.6 Middle East & Africa Taurine and Derivatives Sales Growth
5 AMERICAS
5.1 Americas Taurine and Derivatives Sales by Country
5.1.1 Americas Taurine and Derivatives Sales by Country (2021-2026)
5.1.2 Americas Taurine and Derivatives Revenue by Country (2021-2026)
5.2 Americas Taurine and Derivatives Sales by Type (2021-2026)
5.3 Americas Taurine and Derivatives Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Taurine and Derivatives Sales by Region
6.1.1 APAC Taurine and Derivatives Sales by Region (2021-2026)
6.1.2 APAC Taurine and Derivatives Revenue by Region (2021-2026)
6.2 APAC Taurine and Derivatives Sales by Type (2021-2026)
6.3 APAC Taurine and Derivatives Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Taurine and Derivatives by Country
7.1.1 Europe Taurine and Derivatives Sales by Country (2021-2026)
7.1.2 Europe Taurine and Derivatives Revenue by Country (2021-2026)
7.2 Europe Taurine and Derivatives Sales by Type (2021-2026)
7.3 Europe Taurine and Derivatives Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Taurine and Derivatives by Country
8.1.1 Middle East & Africa Taurine and Derivatives Sales by Country (2021-2026)
8.1.2 Middle East & Africa Taurine and Derivatives Revenue by Country (2021-2026)
8.2 Middle East & Africa Taurine and Derivatives Sales by Type (2021-2026)
8.3 Middle East & Africa Taurine and Derivatives Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Taurine and Derivatives
10.3 Manufacturing Process Analysis of Taurine and Derivatives
10.4 Industry Chain Structure of Taurine and Derivatives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Taurine and Derivatives Distributors
11.3 Taurine and Derivatives Customer
12 WORLD FORECAST REVIEW FOR TAURINE AND DERIVATIVES BY GEOGRAPHIC REGION
12.1 Global Taurine and Derivatives Market Size Forecast by Region
12.1.1 Global Taurine and Derivatives Forecast by Region (2027-2032)
12.1.2 Global Taurine and Derivatives Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Taurine and Derivatives Forecast by Type (2027-2032)
12.7 Global Taurine and Derivatives Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Yongan Pharmaceutical
13.1.1 Yongan Pharmaceutical Company Information
13.1.2 Yongan Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
13.1.3 Yongan Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Yongan Pharmaceutical Main Business Overview
13.1.5 Yongan Pharmaceutical Latest Developments
13.2 Grand Pharma
13.2.1 Grand Pharma Company Information
13.2.2 Grand Pharma Taurine and Derivatives Product Portfolios and Specifications
13.2.3 Grand Pharma Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Grand Pharma Main Business Overview
13.2.5 Grand Pharma Latest Developments
13.3 Jiangyin Huachang
13.3.1 Jiangyin Huachang Company Information
13.3.2 Jiangyin Huachang Taurine and Derivatives Product Portfolios and Specifications
13.3.3 Jiangyin Huachang Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jiangyin Huachang Main Business Overview
13.3.5 Jiangyin Huachang Latest Developments
13.4 Yuanyang Pharmaceutical
13.4.1 Yuanyang Pharmaceutical Company Information
13.4.2 Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
13.4.3 Yuanyang Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Yuanyang Pharmaceutical Main Business Overview
13.4.5 Yuanyang Pharmaceutical Latest Developments
13.5 Taisho Pharmaceutical
13.5.1 Taisho Pharmaceutical Company Information
13.5.2 Taisho Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
13.5.3 Taisho Pharmaceutical Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Taisho Pharmaceutical Main Business Overview
13.5.5 Taisho Pharmaceutical Latest Developments
13.6 Zhejiang NHU Co., Ltd
13.6.1 Zhejiang NHU Co., Ltd Company Information
13.6.2 Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolios and Specifications
13.6.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Zhejiang NHU Co., Ltd Main Business Overview
13.6.5 Zhejiang NHU Co., Ltd Latest Developments
13.7 Shengyuan Environmental Protection
13.7.1 Shengyuan Environmental Protection Company Information
13.7.2 Shengyuan Environmental Protection Taurine and Derivatives Product Portfolios and Specifications
13.7.3 Shengyuan Environmental Protection Taurine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shengyuan Environmental Protection Main Business Overview
13.7.5 Shengyuan Environmental Protection Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Taurine and Derivatives Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Taurine and Derivatives Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Taurine
Table 4. Major Players of Taurine Derivatives
Table 5. Global Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 6. Global Taurine and Derivatives Sales Market Share by Type (2021-2026)
Table 7. Global Taurine and Derivatives Revenue by Type (2021-2026) & ($ million)
Table 8. Global Taurine and Derivatives Revenue Market Share by Type (2021-2026)
Table 9. Global Taurine and Derivatives Sale Price by Type (2021-2026) & (US$/Ton)
Table 10. Global Taurine and Derivatives Sale by Application (2021-2026) & (Tons)
Table 11. Global Taurine and Derivatives Sale Market Share by Application (2021-2026)
Table 12. Global Taurine and Derivatives Revenue by Application (2021-2026) & ($ million)
Table 13. Global Taurine and Derivatives Revenue Market Share by Application (2021-2026)
Table 14. Global Taurine and Derivatives Sale Price by Application (2021-2026) & (US$/Ton)
Table 15. Global Taurine and Derivatives Sales by Company (2021-2026) & (Tons)
Table 16. Global Taurine and Derivatives Sales Market Share by Company (2021-2026)
Table 17. Global Taurine and Derivatives Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Taurine and Derivatives Revenue Market Share by Company (2021-2026)
Table 19. Global Taurine and Derivatives Sale Price by Company (2021-2026) & (US$/Ton)
Table 20. Key Manufacturers Taurine and Derivatives Producing Area Distribution and Sales Area
Table 21. Players Taurine and Derivatives Products Offered
Table 22. Taurine and Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Taurine and Derivatives Sales by Geographic Region (2021-2026) & (Tons)
Table 26. Global Taurine and Derivatives Sales Market Share Geographic Region (2021-2026)
Table 27. Global Taurine and Derivatives Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Taurine and Derivatives Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Taurine and Derivatives Sales by Country/Region (2021-2026) & (Tons)
Table 30. Global Taurine and Derivatives Sales Market Share by Country/Region (2021-2026)
Table 31. Global Taurine and Derivatives Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Taurine and Derivatives Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Taurine and Derivatives Sales by Country (2021-2026) & (Tons)
Table 34. Americas Taurine and Derivatives Sales Market Share by Country (2021-2026)
Table 35. Americas Taurine and Derivatives Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 37. Americas Taurine and Derivatives Sales by Application (2021-2026) & (Tons)
Table 38. APAC Taurine and Derivatives Sales by Region (2021-2026) & (Tons)
Table 39. APAC Taurine and Derivatives Sales Market Share by Region (2021-2026)
Table 40. APAC Taurine and Derivatives Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 42. APAC Taurine and Derivatives Sales by Application (2021-2026) & (Tons)
Table 43. Europe Taurine and Derivatives Sales by Country (2021-2026) & (Tons)
Table 44. Europe Taurine and Derivatives Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 46. Europe Taurine and Derivatives Sales by Application (2021-2026) & (Tons)
Table 47. Middle East & Africa Taurine and Derivatives Sales by Country (2021-2026) & (Tons)
Table 48. Middle East & Africa Taurine and Derivatives Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 50. Middle East & Africa Taurine and Derivatives Sales by Application (2021-2026) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Taurine and Derivatives
Table 52. Key Market Challenges & Risks of Taurine and Derivatives
Table 53. Key Industry Trends of Taurine and Derivatives
Table 54. Taurine and Derivatives Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Taurine and Derivatives Distributors List
Table 57. Taurine and Derivatives Customer List
Table 58. Global Taurine and Derivatives Sales Forecast by Region (2027-2032) & (Tons)
Table 59. Global Taurine and Derivatives Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Taurine and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 61. Americas Taurine and Derivatives Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Taurine and Derivatives Sales Forecast by Region (2027-2032) & (Tons)
Table 63. APAC Taurine and Derivatives Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Taurine and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 65. Europe Taurine and Derivatives Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Taurine and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 67. Middle East & Africa Taurine and Derivatives Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Taurine and Derivatives Sales Forecast by Type (2027-2032) & (Tons)
Table 69. Global Taurine and Derivatives Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Taurine and Derivatives Sales Forecast by Application (2027-2032) & (Tons)
Table 71. Global Taurine and Derivatives Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Yongan Pharmaceutical Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 73. Yongan Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
Table 74. Yongan Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 75. Yongan Pharmaceutical Main Business
Table 76. Yongan Pharmaceutical Latest Developments
Table 77. Grand Pharma Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 78. Grand Pharma Taurine and Derivatives Product Portfolios and Specifications
Table 79. Grand Pharma Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 80. Grand Pharma Main Business
Table 81. Grand Pharma Latest Developments
Table 82. Jiangyin Huachang Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangyin Huachang Taurine and Derivatives Product Portfolios and Specifications
Table 84. Jiangyin Huachang Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 85. Jiangyin Huachang Main Business
Table 86. Jiangyin Huachang Latest Developments
Table 87. Yuanyang Pharmaceutical Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 88. Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
Table 89. Yuanyang Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 90. Yuanyang Pharmaceutical Main Business
Table 91. Yuanyang Pharmaceutical Latest Developments
Table 92. Taisho Pharmaceutical Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 93. Taisho Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
Table 94. Taisho Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 95. Taisho Pharmaceutical Main Business
Table 96. Taisho Pharmaceutical Latest Developments
Table 97. Zhejiang NHU Co., Ltd Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 98. Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolios and Specifications
Table 99. Zhejiang NHU Co., Ltd Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 100. Zhejiang NHU Co., Ltd Main Business
Table 101. Zhejiang NHU Co., Ltd Latest Developments
Table 102. Shengyuan Environmental Protection Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 103. Shengyuan Environmental Protection Taurine and Derivatives Product Portfolios and Specifications
Table 104. Shengyuan Environmental Protection Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 105. Shengyuan Environmental Protection Main Business
Table 106. Shengyuan Environmental Protection Latest Developments
Table 1. Taurine and Derivatives Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Taurine and Derivatives Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Taurine
Table 4. Major Players of Taurine Derivatives
Table 5. Global Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 6. Global Taurine and Derivatives Sales Market Share by Type (2021-2026)
Table 7. Global Taurine and Derivatives Revenue by Type (2021-2026) & ($ million)
Table 8. Global Taurine and Derivatives Revenue Market Share by Type (2021-2026)
Table 9. Global Taurine and Derivatives Sale Price by Type (2021-2026) & (US$/Ton)
Table 10. Global Taurine and Derivatives Sale by Application (2021-2026) & (Tons)
Table 11. Global Taurine and Derivatives Sale Market Share by Application (2021-2026)
Table 12. Global Taurine and Derivatives Revenue by Application (2021-2026) & ($ million)
Table 13. Global Taurine and Derivatives Revenue Market Share by Application (2021-2026)
Table 14. Global Taurine and Derivatives Sale Price by Application (2021-2026) & (US$/Ton)
Table 15. Global Taurine and Derivatives Sales by Company (2021-2026) & (Tons)
Table 16. Global Taurine and Derivatives Sales Market Share by Company (2021-2026)
Table 17. Global Taurine and Derivatives Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Taurine and Derivatives Revenue Market Share by Company (2021-2026)
Table 19. Global Taurine and Derivatives Sale Price by Company (2021-2026) & (US$/Ton)
Table 20. Key Manufacturers Taurine and Derivatives Producing Area Distribution and Sales Area
Table 21. Players Taurine and Derivatives Products Offered
Table 22. Taurine and Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Taurine and Derivatives Sales by Geographic Region (2021-2026) & (Tons)
Table 26. Global Taurine and Derivatives Sales Market Share Geographic Region (2021-2026)
Table 27. Global Taurine and Derivatives Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Taurine and Derivatives Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Taurine and Derivatives Sales by Country/Region (2021-2026) & (Tons)
Table 30. Global Taurine and Derivatives Sales Market Share by Country/Region (2021-2026)
Table 31. Global Taurine and Derivatives Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Taurine and Derivatives Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Taurine and Derivatives Sales by Country (2021-2026) & (Tons)
Table 34. Americas Taurine and Derivatives Sales Market Share by Country (2021-2026)
Table 35. Americas Taurine and Derivatives Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 37. Americas Taurine and Derivatives Sales by Application (2021-2026) & (Tons)
Table 38. APAC Taurine and Derivatives Sales by Region (2021-2026) & (Tons)
Table 39. APAC Taurine and Derivatives Sales Market Share by Region (2021-2026)
Table 40. APAC Taurine and Derivatives Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 42. APAC Taurine and Derivatives Sales by Application (2021-2026) & (Tons)
Table 43. Europe Taurine and Derivatives Sales by Country (2021-2026) & (Tons)
Table 44. Europe Taurine and Derivatives Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 46. Europe Taurine and Derivatives Sales by Application (2021-2026) & (Tons)
Table 47. Middle East & Africa Taurine and Derivatives Sales by Country (2021-2026) & (Tons)
Table 48. Middle East & Africa Taurine and Derivatives Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Taurine and Derivatives Sales by Type (2021-2026) & (Tons)
Table 50. Middle East & Africa Taurine and Derivatives Sales by Application (2021-2026) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Taurine and Derivatives
Table 52. Key Market Challenges & Risks of Taurine and Derivatives
Table 53. Key Industry Trends of Taurine and Derivatives
Table 54. Taurine and Derivatives Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Taurine and Derivatives Distributors List
Table 57. Taurine and Derivatives Customer List
Table 58. Global Taurine and Derivatives Sales Forecast by Region (2027-2032) & (Tons)
Table 59. Global Taurine and Derivatives Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Taurine and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 61. Americas Taurine and Derivatives Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Taurine and Derivatives Sales Forecast by Region (2027-2032) & (Tons)
Table 63. APAC Taurine and Derivatives Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Taurine and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 65. Europe Taurine and Derivatives Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Taurine and Derivatives Sales Forecast by Country (2027-2032) & (Tons)
Table 67. Middle East & Africa Taurine and Derivatives Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Taurine and Derivatives Sales Forecast by Type (2027-2032) & (Tons)
Table 69. Global Taurine and Derivatives Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Taurine and Derivatives Sales Forecast by Application (2027-2032) & (Tons)
Table 71. Global Taurine and Derivatives Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Yongan Pharmaceutical Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 73. Yongan Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
Table 74. Yongan Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 75. Yongan Pharmaceutical Main Business
Table 76. Yongan Pharmaceutical Latest Developments
Table 77. Grand Pharma Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 78. Grand Pharma Taurine and Derivatives Product Portfolios and Specifications
Table 79. Grand Pharma Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 80. Grand Pharma Main Business
Table 81. Grand Pharma Latest Developments
Table 82. Jiangyin Huachang Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangyin Huachang Taurine and Derivatives Product Portfolios and Specifications
Table 84. Jiangyin Huachang Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 85. Jiangyin Huachang Main Business
Table 86. Jiangyin Huachang Latest Developments
Table 87. Yuanyang Pharmaceutical Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 88. Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
Table 89. Yuanyang Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 90. Yuanyang Pharmaceutical Main Business
Table 91. Yuanyang Pharmaceutical Latest Developments
Table 92. Taisho Pharmaceutical Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 93. Taisho Pharmaceutical Taurine and Derivatives Product Portfolios and Specifications
Table 94. Taisho Pharmaceutical Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 95. Taisho Pharmaceutical Main Business
Table 96. Taisho Pharmaceutical Latest Developments
Table 97. Zhejiang NHU Co., Ltd Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 98. Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolios and Specifications
Table 99. Zhejiang NHU Co., Ltd Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 100. Zhejiang NHU Co., Ltd Main Business
Table 101. Zhejiang NHU Co., Ltd Latest Developments
Table 102. Shengyuan Environmental Protection Basic Information, Taurine and Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 103. Shengyuan Environmental Protection Taurine and Derivatives Product Portfolios and Specifications
Table 104. Shengyuan Environmental Protection Taurine and Derivatives Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 105. Shengyuan Environmental Protection Main Business
Table 106. Shengyuan Environmental Protection Latest Developments
LIST OF FIGURES
Figure 1. Picture of Taurine and Derivatives
Figure 2. Taurine and Derivatives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Taurine and Derivatives Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Taurine and Derivatives Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Taurine and Derivatives Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Taurine and Derivatives Sales Market Share by Country/Region (2025)
Figure 10. Taurine and Derivatives Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Taurine
Figure 12. Product Picture of Taurine Derivatives
Figure 13. Global Taurine and Derivatives Sales Market Share by Type in 2026
Figure 14. Global Taurine and Derivatives Revenue Market Share by Type (2021-2026)
Figure 15. Taurine and Derivatives Consumed in Food and Beverages
Figure 16. Global Taurine and Derivatives Market: Food and Beverages (2021-2026) & (Tons)
Figure 17. Taurine and Derivatives Consumed in Medicine and Health Products
Figure 18. Global Taurine and Derivatives Market: Medicine and Health Products (2021-2026) & (Tons)
Figure 19. Taurine and Derivatives Consumed in Feed
Figure 20. Global Taurine and Derivatives Market: Feed (2021-2026) & (Tons)
Figure 21. Taurine and Derivatives Consumed in Pet Food
Figure 22. Global Taurine and Derivatives Market: Pet Food (2021-2026) & (Tons)
Figure 23. Taurine and Derivatives Consumed in Others
Figure 24. Global Taurine and Derivatives Market: Others (2021-2026) & (Tons)
Figure 25. Global Taurine and Derivatives Sale Market Share by Application (2025)
Figure 26. Global Taurine and Derivatives Revenue Market Share by Application in 2026
Figure 27. Taurine and Derivatives Sales by Company in 2026 (Tons)
Figure 28. Global Taurine and Derivatives Sales Market Share by Company in 2026
Figure 29. Taurine and Derivatives Revenue by Company in 2026 ($ millions)
Figure 30. Global Taurine and Derivatives Revenue Market Share by Company in 2026
Figure 31. Global Taurine and Derivatives Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Taurine and Derivatives Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Taurine and Derivatives Sales 2021-2026 (Tons)
Figure 34. Americas Taurine and Derivatives Revenue 2021-2026 ($ millions)
Figure 35. APAC Taurine and Derivatives Sales 2021-2026 (Tons)
Figure 36. APAC Taurine and Derivatives Revenue 2021-2026 ($ millions)
Figure 37. Europe Taurine and Derivatives Sales 2021-2026 (Tons)
Figure 38. Europe Taurine and Derivatives Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Taurine and Derivatives Sales 2021-2026 (Tons)
Figure 40. Middle East & Africa Taurine and Derivatives Revenue 2021-2026 ($ millions)
Figure 41. Americas Taurine and Derivatives Sales Market Share by Country in 2026
Figure 42. Americas Taurine and Derivatives Revenue Market Share by Country (2021-2026)
Figure 43. Americas Taurine and Derivatives Sales Market Share by Type (2021-2026)
Figure 44. Americas Taurine and Derivatives Sales Market Share by Application (2021-2026)
Figure 45. United States Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Taurine and Derivatives Sales Market Share by Region in 2026
Figure 50. APAC Taurine and Derivatives Revenue Market Share by Region (2021-2026)
Figure 51. APAC Taurine and Derivatives Sales Market Share by Type (2021-2026)
Figure 52. APAC Taurine and Derivatives Sales Market Share by Application (2021-2026)
Figure 53. China Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 57. India Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Taurine and Derivatives Sales Market Share by Country in 2026
Figure 61. Europe Taurine and Derivatives Revenue Market Share by Country (2021-2026)
Figure 62. Europe Taurine and Derivatives Sales Market Share by Type (2021-2026)
Figure 63. Europe Taurine and Derivatives Sales Market Share by Application (2021-2026)
Figure 64. Germany Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 65. France Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Taurine and Derivatives Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Taurine and Derivatives Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Taurine and Derivatives Sales Market Share by Application (2021-2026)
Figure 72. Egypt Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Taurine and Derivatives in 2026
Figure 78. Manufacturing Process Analysis of Taurine and Derivatives
Figure 79. Industry Chain Structure of Taurine and Derivatives
Figure 80. Channels of Distribution
Figure 81. Global Taurine and Derivatives Sales Market Forecast by Region (2027-2032)
Figure 82. Global Taurine and Derivatives Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Taurine and Derivatives Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Taurine and Derivatives Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Taurine and Derivatives Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Taurine and Derivatives Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Taurine and Derivatives
Figure 2. Taurine and Derivatives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Taurine and Derivatives Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Taurine and Derivatives Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Taurine and Derivatives Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Taurine and Derivatives Sales Market Share by Country/Region (2025)
Figure 10. Taurine and Derivatives Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Taurine
Figure 12. Product Picture of Taurine Derivatives
Figure 13. Global Taurine and Derivatives Sales Market Share by Type in 2026
Figure 14. Global Taurine and Derivatives Revenue Market Share by Type (2021-2026)
Figure 15. Taurine and Derivatives Consumed in Food and Beverages
Figure 16. Global Taurine and Derivatives Market: Food and Beverages (2021-2026) & (Tons)
Figure 17. Taurine and Derivatives Consumed in Medicine and Health Products
Figure 18. Global Taurine and Derivatives Market: Medicine and Health Products (2021-2026) & (Tons)
Figure 19. Taurine and Derivatives Consumed in Feed
Figure 20. Global Taurine and Derivatives Market: Feed (2021-2026) & (Tons)
Figure 21. Taurine and Derivatives Consumed in Pet Food
Figure 22. Global Taurine and Derivatives Market: Pet Food (2021-2026) & (Tons)
Figure 23. Taurine and Derivatives Consumed in Others
Figure 24. Global Taurine and Derivatives Market: Others (2021-2026) & (Tons)
Figure 25. Global Taurine and Derivatives Sale Market Share by Application (2025)
Figure 26. Global Taurine and Derivatives Revenue Market Share by Application in 2026
Figure 27. Taurine and Derivatives Sales by Company in 2026 (Tons)
Figure 28. Global Taurine and Derivatives Sales Market Share by Company in 2026
Figure 29. Taurine and Derivatives Revenue by Company in 2026 ($ millions)
Figure 30. Global Taurine and Derivatives Revenue Market Share by Company in 2026
Figure 31. Global Taurine and Derivatives Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Taurine and Derivatives Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Taurine and Derivatives Sales 2021-2026 (Tons)
Figure 34. Americas Taurine and Derivatives Revenue 2021-2026 ($ millions)
Figure 35. APAC Taurine and Derivatives Sales 2021-2026 (Tons)
Figure 36. APAC Taurine and Derivatives Revenue 2021-2026 ($ millions)
Figure 37. Europe Taurine and Derivatives Sales 2021-2026 (Tons)
Figure 38. Europe Taurine and Derivatives Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Taurine and Derivatives Sales 2021-2026 (Tons)
Figure 40. Middle East & Africa Taurine and Derivatives Revenue 2021-2026 ($ millions)
Figure 41. Americas Taurine and Derivatives Sales Market Share by Country in 2026
Figure 42. Americas Taurine and Derivatives Revenue Market Share by Country (2021-2026)
Figure 43. Americas Taurine and Derivatives Sales Market Share by Type (2021-2026)
Figure 44. Americas Taurine and Derivatives Sales Market Share by Application (2021-2026)
Figure 45. United States Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Taurine and Derivatives Sales Market Share by Region in 2026
Figure 50. APAC Taurine and Derivatives Revenue Market Share by Region (2021-2026)
Figure 51. APAC Taurine and Derivatives Sales Market Share by Type (2021-2026)
Figure 52. APAC Taurine and Derivatives Sales Market Share by Application (2021-2026)
Figure 53. China Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 57. India Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Taurine and Derivatives Sales Market Share by Country in 2026
Figure 61. Europe Taurine and Derivatives Revenue Market Share by Country (2021-2026)
Figure 62. Europe Taurine and Derivatives Sales Market Share by Type (2021-2026)
Figure 63. Europe Taurine and Derivatives Sales Market Share by Application (2021-2026)
Figure 64. Germany Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 65. France Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Taurine and Derivatives Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Taurine and Derivatives Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Taurine and Derivatives Sales Market Share by Application (2021-2026)
Figure 72. Egypt Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Taurine and Derivatives Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Taurine and Derivatives in 2026
Figure 78. Manufacturing Process Analysis of Taurine and Derivatives
Figure 79. Industry Chain Structure of Taurine and Derivatives
Figure 80. Channels of Distribution
Figure 81. Global Taurine and Derivatives Sales Market Forecast by Region (2027-2032)
Figure 82. Global Taurine and Derivatives Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Taurine and Derivatives Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Taurine and Derivatives Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Taurine and Derivatives Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Taurine and Derivatives Revenue Market Share Forecast by Application (2027-2032)
